| 000 | 00905nam a2200229 a 4500 | ||
|---|---|---|---|
| 008 | 130620s2013^^^^enka^^^^^^^^^^000^0^eng^d | ||
| 020 | _a9781439853887 | ||
| 035 | _aMX001001611360 | ||
| 040 |
_aUNAMX _bspa _erda _cUNAMX _dUNAMX |
||
| 050 | 4 |
_aRS431.P75 _bP43 2013 |
|
| 245 | 0 | 0 |
_aPharmaceutical formulation development of peptides and proteins / _cedited by Lars Hovgaard, Sven Frokjaer, Marco van de Weert |
| 250 | _asecond edition | ||
| 264 | 1 |
_aBoca Raton : _bCRC Press/Taylor & Francis Group, _cc2013 |
|
| 300 |
_axi, 376 páginas : _bilustraciones |
||
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 650 | 4 | _aMedicamentos proteicos | |
| 700 | 1 |
_aHovgaard, Lars, _d1962- , _eeditor de la compilación |
|
| 700 | 1 |
_aFrokjaer, Sven, _d1947- , _eeditor de la compilación |
|
| 700 | 1 |
_aWeert, Marco van de, _eeditor de la compilación |
|
| 999 |
_c3105 _d3105 |
||